Biotechnology companies can use “value-chain analysis” to create processes ... the long-term, strategic importance of intellectual property (IP) can fade into the background.

Analysis of MNCs and companies ... India and China have emerged as an important destination for outsourcing and offshoring by MNCs across the pharma value chain – from R&amp,D to late stage ...